Errors in Table 3, Outcome Measures, Results, Supplement 1, and Supplement 2

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMusculoskeletal pain and rehabilitation · Health Systems, Economic Evaluations, Quality of Life · Workplace Health and Well-being
In the Original Investigation titled, “Efficacy of Therapeutic Aquatic Exercise vs Physical Therapy Modalities for Patients With Chronic Low Back Pain: A Randomized Clinical Trial,”^1^ published January 7, 2022, there were errors in the article text, Table 3, and Supplements 1 and 2. First, a numeric error appeared in Table 3. The value for FABQ total category at 3 months in the physical therapy modalities group given as “23.32” should have been “33.32.” In addition, the trial protocol in Supplement 1 included pain as a primary outcome, which was not consistent with the published article. Other secondary outcomes were missing from the Outcomes Measures. The minimal clinically important findings in Results required updates. Finally, eTable 1 of Supplement 2 categories were given incorrectly with results of statistical tests that should not have been included for baseline characteristics, and eTable 2 contained entry errors on the rating scale for assessment of pain. The authors have explained what happened in a Comment,^2^ and this article has been corrected with updated Supplement materials.^1^
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Peng MS, Wang R, Wang YZ, . Efficacy of therapeutic aquatic exercise vs physical therapy modalities for patients with chronic low back pain: a randomized clinical trial. JAMA Netw Open. 2022;5(1):e 2142069. doi:10.1001/jamanetworkopen.2021.4206934994794 PMC 8742191 · doi ↗ · pubmed ↗
- 2Peng MS. Revised discrepancies. Comment. JAMA Network Open. March 5, 2024. Accessed March 5, 2024. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2787713
